Expected industry segment: overseas medical equipment such as high-value consumables, surgical instruments, except for diagnostic equipment;
Investment phase: unlimited, considering early projects, preferably FDA-cleared/CE-certified targets or targets pending CE mark approval - co-investment also acceptable;
Expected investment region: Europe & America, Japan, Israel;
Investment amount: unlimited, $5m-50m;
As a domestic group focusing on the medical device industry, the company has more than 1,500 distributors and a platform worth more than 12 billion yuan (2018). The company has previous experience of investing in Japanese projects.